Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 29, Issue 1, 2009, Pages 81-88

  Hwang, Young Hwan ^a   Son, Min Jeong ^a   Yang, Jaeseok ^b   Kim, Kiwon ^c   Chung, Wookyung ^b   Joo, Kwon Wook ^a   Kim, Yonsu ^a   Ahn, Curie ^a,d   Oh, Kook Hwan ^a,d  

^a Seoul National University Hospital   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Interleukin 6; Single nucleotide polymorphism

Indexed keywords

CREATININE; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; DIALYSIS FLUID; DNA;

ADOLESCENT; ADULT; ARTICLE; CREATININE BLOOD LEVEL; DIALYSATE LEVEL; FEMALE; FLUID TRANSPORT; GENE FREQUENCY; GENE IDENTIFICATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CLEARANCE; KOREA; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PERITONEAL SOLUTE TRANSPORT RATE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ACTIVE TRANSPORT; CHEMISTRY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY;

BIOLOGICAL TRANSPORT, ACTIVE; DIALYSIS SOLUTIONS; DNA; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; KOREA; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 65349098769     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900112     Document Type: Article

References (32)

1. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9:1285-92.
2. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13:1242-9.
3. Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006; 17:271-8.
4. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17:2591-8.
5. Heaf J. Pathogenic effects of a high peritoneal transport rate. Semin Dial 2000; 13:188-93.
6. Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW. Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 2004; 43:492-501.
7. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int 2005; 67:1216-33.
8. Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romao JE Jr, et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17:1480-6.
9. Gillerot G, Goffin E, Michel C, Evenepoel P, van Biesen W, Tintillier M, et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67:2477-87.
10. Smit W, van Dijk P, Langedijk MJ, Schouten N, van den Berg N, Struijk DG, et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23:440-9.
11. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989; 5:303-11; Discussion: 312-13.
12. Raj DS, Langos V, Gangam N, Roscoe J. Ethnic variability in peritoneal equilibration test and urea kinetics. Am J Kidney Dis 1997; 30:374-81.
13. Selgas R, Bajo MA, Cirugeda A, del Peso G, Valdes J, Castro MJ, et al. Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function. Perit Dial Int 2005; 25:68-76.
14. Nakamoto H, Imai H, Kawanishi H, Nakamoto M, Minakuchi J, Kumon S, et al. Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD. Am J Kidney Dis 2002; 40:1045-54.
15. Selgas R, Bajo MA, Castro MJ, del Peso G, Aguilera A, Fernandez-Perpen A, et al. Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysis. Perit Dial Int 2000; 20:631-6.
16. Rubin J, Rust P, Brown P, Popovich RP, Nolph KD. A comparison of peritoneal transport in patients with psoriasis and uremia. Nephron 1981; 29:185-9.
17. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002; 17:1085-92.
18. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66:2437-45.
19. Axelsson J, Devuyst O, Nordfors L, Heimburger O, Stenvinkel P, Lindholm B. Place of genotyping and phenotyping in understanding and potentially modifying outcomes in peritoneal dialysis patients. Kidney Int Suppl 2006; 103:S138-45.
20. Szeto CC, Poon P, Szeto CY, Wong TY, Lai KB, Li PK. Plasminogen activator inhibitor-1 4G/5G genetic polymorphism does not affect peritoneal transport characteristic. Am J Kidney Dis 2002; 39:1061-7.
21. Wong TY, Szeto CC, Szeto CY, Lai KB, Chow KM, Li PK. Association of eNOS polymorphism with basal peritoneal membrane function in uremic patients. Am J Kidney Dis 2003; 42:781-6.
22. Szeio CC, Chow KM, Poon P, Szeto CYK, Wong TYH, Li PKT. Genetic polymorphism of VEGF: impact on longitudinal change of peritoneal transport and survival of peritoneal. dialysis patients. Kidney Int 2004; 65:1947-55.
23. Chung SH, Heimburger 0, Stenvinkel P, Bergstrom J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 16:2240-5.
24. Margetts PJ, McMullin JP, Rabbat CG, Churchill DN. Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Diat Int 2000; 20:14-18.
25. Pecoits-Filho R, Carvalho MJ, Stenvinkel P, Lindholm B, Heimburger O. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis. Perit Dial Int 2006; 26:53-63.
26. Oh KH, Moon JY, Oh J, Kim SG, Hwang YH, Kim S, et al. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients. Nephrol Dial Transplant 2008; 23:2356-64.
27. Witowski J, Jorres A, Coles GA, Williams JD, Topley N. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA. Kidney Int 1996; 50:1212-23.
28. van Esch S, Zweers MM, Jansen MA, de Waart DR, van Manen JG, Krediet RT. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int 2004; 24:554-61.
29. Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, Silva F, et al. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant 2006; 21: 763-9.
30. Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, et al. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol 2007; 27-84-91.
31. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6-transcriptional regulation. J Biol Chem 2000; 275:18138-44.
32. Noponen-Hietala N, Virtanen I, Karttunen R, Schwenke Jakkula E, Li H, et al. Genetic variations in IL6 associate with intervertebral disc disease characterized by sciatica. Pain 2005; 114(1-2):186-94.